Advertisement

Hereditary Cancer Risk

  • Jennifer E. Axilbund
  • Beth N. Peshkin
Chapter
Part of the Issues in Clinical Child Psychology book series (ICCP)

Abstract

The elucidation of the sequence of the human genome promises to usher in a new era of medicine that will result in improved diagnosis and identification of individuals at risk for hereditary conditions. In this chapter, we focus on genetic testing for hereditary cancer risk in children and families and how such testing impacts the management of children with a diagnosis of cancer or who are at risk for cancer. We provide descriptions of the major hereditary cancers and cancer syndromes affecting children, as well as cancer predisposition syndromes that occur primarily in adulthood, but for which testing in minors has been raised as consideration. The impact on children’s medical management will be reviewed, as well as data on the psychosocial effects of testing. It is important to note that a hallmark feature of an inherited predisposition to cancer is that affected individuals are usually at high risk of developing more than one type of malignancy; thus, screening and risk reduction guidelines are often targeted to more than one site or system. Because of the potential for considerable morbidity and mortality arising from hereditary cancers, the psychosocial impact may be significant for the individual and family.

Keywords

Genetic Testing Down Syndrome Familial Adenomatous Polyposis Tuberous Sclerosis Complex Fanconi Anemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21, 2397–2406.CrossRefGoogle Scholar
  2. Andrews, L., Mireskandari, S., Jessen, J., Thewes, B., Solomon, M., Macrae, F., et al. (2006). Impact of familial adenomatous polyposis on young adults: Attitudes toward genetic testing, support, and information needs. Genetics in Medicine, 8, 697–703.PubMedCrossRefGoogle Scholar
  3. Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2testing. Cancer Epidemiology, Biomarkers, and Prevention, 9, 1251–1254.Google Scholar
  4. Baumann, S. L. (2006). Family Systems Genetic Illness Model-breast cancer. Clinical Journal of Oncology Nursing, 10, 377–381.PubMedCrossRefGoogle Scholar
  5. Borry, P., Goffin, T., Nys, H., & Dierickx, K. (2008). Attitudes regarding predictive genetic testing in minors. A survey of European clinical geneticists. American Journal of Medical Genetics Part C Seminars in Medical Genetics, 148, 78–83.CrossRefGoogle Scholar
  6. Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clinical Genetics, 70, 374–381.PubMedCrossRefGoogle Scholar
  7. Bradbury, A. R., Dignam, J. J., Ibe, C. N., Auh, S., Hlubocky, F. J., Cummings, S. A., et al. (2007). How often do BRCAmutation carriers tell their young children of the family’s risk for cancer? A study of parental disclosure of BRCAmutations to minors and young adults. Journal of Clinical Oncology, 25, 3705–3711.PubMedCrossRefGoogle Scholar
  8. Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., Olopade, O. I., et al. (2008). Should genetic testing for BRCA1/2be permitted for minors? Opinions of BRCAmutation carriers and their adult offspring. American Journal of Medical Genetics Part C Seminars in Medical Genetics, 148, 70–77.CrossRefGoogle Scholar
  9. Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., Hlubokcy, F., et al. (2009). Learning of your parent’s BRCAmutation during adolescence or early adulthood: A study of offspring experiences. Psycho-oncology, 18, 200–208.CrossRefGoogle Scholar
  10. Brandi, M. L., Gagel, R. F., Angeli, A., Bilezikian, J. P., Beck-Peccoz, P., Bordi, C., et al. (2001). Guidelines for diagnosis and therapy of MEN type 1 and type 2. The Journal of Clinical Endocrinology and Metabolism, 86, 5658–5671.PubMedCrossRefGoogle Scholar
  11. Brosens, L. A., van Hattem, A., Hylind, L. M., Iacobuzio-Donahue, C., Romans, K. E., Axilbund, J., et al. (2007). Risk of colorectal cancer in juvenile polyposis. Gut, 56, 965–967.PubMedCrossRefGoogle Scholar
  12. Cappelli, M., Verma, S., Korneluk, Y., Hunter, A., Tomiak, E., Allanson, J., et al. (2005). Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer. Clinical Genetics, 67, 481–491.PubMedCrossRefGoogle Scholar
  13. Cella, D., Hughes, C., Peterman, A., Chang, C. H., Peshkin, B. N., Schwartz, M. D., et al. (2002). A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychology, 21, 565–572.CrossRefGoogle Scholar
  14. Chompret, A., Brugieres, L., Ronsin, M., Gardes, M., Dessarps-Freichey, F., Abel, A., et al. (2000). P53germline mutations in childhood cancers and cancer risk for carrier individuals. British Journal of Cancer, 82, 1932–1937.PubMedCrossRefGoogle Scholar
  15. Church, J., & Simmang, C. (2003). Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Diseases of the Colon and Rectum, 46, 1001–1012.PubMedCrossRefGoogle Scholar
  16. Clarke, S., Butler, K., & Esplen, M. J. (2008). The phases of disclosing BRCA1/2genetic information to offspring. Psycho-oncology, 17, 797–803.PubMedCrossRefGoogle Scholar
  17. Cleiren, M. P., Oskam, W., & Lips, C. J. (1989). Living with a hereditary form of cancer: Experiences and needs of MEN 2 patients and their families. Henry Ford Hospital Medical Journal, 37, 164–166.PubMedGoogle Scholar
  18. Codori, A. M., Petersen, G. M., Boyd, P. A., Brandt, J., & Giardiello, F. M. (1996). Genetic testing for cancer in children. Short-term psychological effect. Archives of Pediatrics and Adolescent Medicine, 150, 1131–1138.PubMedCrossRefGoogle Scholar
  19. Codori, A. M., Zawacki, K. L., Petersen, G. M., Miglioretti, D. L., Bacon, J. A., Trimbath, J. D., et al. (2003). Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. American Journal of Medical Genetics. Part A, 116, 117–128.Google Scholar
  20. Cohen, M. S., & Moley, J. F. (2003). Surgical treatment of medullary thyroid carcinoma. Journal of Internal Medicine, 253, 616–626.PubMedCrossRefGoogle Scholar
  21. Cummings, M. R. (2003). Cytogenetics: Karyotypes and chromosome aberrations. In M. R. Cummings (Ed.), Human heredity: Principles and issues(6th ed., pp. 140–173). Pacific Grove, CA: Wadsworth Group.Google Scholar
  22. Curatolo, P., Bombardieri, R., & Jozwiak, S. (2008). Tuberous sclerosis. Lancet, 372, 657–668.PubMedCrossRefGoogle Scholar
  23. DeMarco, T. A., Peshkin, B. N., Valdimarsdottir, H. B., Patenaude, A. F., Schneider, K. A., & Tercyak, K. P. (2008). Role of parenting relationship quality in communicating about maternal BRCA1/2genetic test results with children. Journal of Genetic Counseling, 17, 283–287.PubMedCrossRefGoogle Scholar
  24. Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). “You’re one of us now”: Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 148, 47–55.CrossRefGoogle Scholar
  25. Duncan, R. E., Savulescu, J., Gillam, L., Williamson, R., & Delatycki, M. B. (2005). An international survey of predictive genetic testing in children for adult onset conditions. Genetics in Medicine, 7, 390–396.PubMedCrossRefGoogle Scholar
  26. Edwards, L., Watson, M., St James-Roberts, I., Ashley, S., Tilney, C., Brougham, B., et al. (2008, March 5). Adolescent’s stress responses and psychological functioning when a parent has early breast cancer. Psycho-oncology, 17(10), 1039–1047. (epub ahead of print).PubMedCrossRefGoogle Scholar
  27. Evans, D. G., Baser, M. E., O’Reilly, B., Rowe, J., Gleeson, M., Saeed, S., et al. (2005). Management of the patient and family with neurofibromatosis 2: A consensus conference statement. British Journal of Neurosurgery, 19, 5–12.PubMedCrossRefGoogle Scholar
  28. Evans, D. G., Huson, S. M., Donnai, D., Neary, W., Blair, V., Newton, V., et al. (1992). A clinical study of type 2 neurofibromatosis. The Quarterly Journal of Medicine, 84, 603–618.PubMedGoogle Scholar
  29. Evans, D. G., Ladusans, E. J., Rimmer, S., Burnell, L. D., Thakker, N., & Farndon, P. A. (1993). Complications of the naevoid basal cell carcinoma syndrome: Results of a population based study. Journal of Medical Genetics, 30, 460–464.PubMedCrossRefGoogle Scholar
  30. Fanos, J. H., & Mackintosh, M. A. (1999). Never again joy without sorrow: The effect on parents of a child with ataxia-telangiectasia. American Journal of Medical Genetics, 87, 413–419.PubMedCrossRefGoogle Scholar
  31. Firth, P. (2006). Patients and their families. Recent Results in Cancer Research, 168, 61–71.PubMedCrossRefGoogle Scholar
  32. Friedrich, R. E. (2007). Diagnosis and treatment of patients with nevoid basal cell carcinoma syndrome [Gorlin-Goltz syndrome (GGS)]. Anticancer Research, 27, 1783–1787.PubMedGoogle Scholar
  33. Gaff, C. L., Lynch, E., & Spencer, L. (2006). Predictive testing of eighteen year olds: Counseling challenges. Journal of Genetic Counseling, 15, 245–251.PubMedCrossRefGoogle Scholar
  34. Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., et al. (2000). Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119, 1447–1453.PubMedCrossRefGoogle Scholar
  35. Giardiello, F. M., & Trimbath, J. D. (2006). Peutz-Jeghers syndrome and management recommendations. Clinical Gastroenterology and Hepatology, 4, 408–415.PubMedCrossRefGoogle Scholar
  36. Godard, B., Pratte, A., Dumont, M., Simard-Lebrun, A., & Simard, J. (2007). Factors associated with an individual’s decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: Implications for counseling. Genetic Testing, 11, 45–54.PubMedCrossRefGoogle Scholar
  37. Gorlin, R. J. (2004). Nevoid basal cell carcinoma (Gorlin) syndrome. Genetics in Medicine, 6, 530–539.PubMedCrossRefGoogle Scholar
  38. Grosfeld, F. J., Beemer, F. A., Lips, C. J., Hendriks, K. S., & ten Kroode, H. F. (2000a). Parents’ responses to disclosure of genetic test results of their children. American Journal of Medical Genetics, 94, 316–323.PubMedCrossRefGoogle Scholar
  39. Grosfeld, F. J., Lips, C. J., Beemer, F. A., Blijham, G. H., Quirijnen, J. M., Mastenbroek, M. P., et al. (2000b). Distress in MEN 2 family members and partners prior to DNA test disclosure. Multiple endocrine neoplasia type 2. American Journal of Medical Genetics, 91, 1–7.PubMedCrossRefGoogle Scholar
  40. Grosfeld, F. J., Lips, C. J., ten Kroode, H. F., Beemer, F. A., van Spijker, H. G., & Brouwers-Smalbraak, G. J. (1996). Psychosocial consequences of DNA analysis for MEN type 2. Oncology, 10, 141–146.PubMedGoogle Scholar
  41. Gutmann, D. H., Aylsworth, A., Carey, J. C., Korf, B., Marks, J., Pyeritz, R. E., et al. (1997). The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. Journal of the American Medical Association, 278, 51–57.PubMedCrossRefGoogle Scholar
  42. Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J., et al. (2006). Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clinical Cancer Research, 12, 3209–3215.PubMedCrossRefGoogle Scholar
  43. Hinds, R., Philp, C., Hyer, W., & Fell, J. M. (2004). Complications of childhood Peutz-Jeghers syndrome: Implications for pediatric screening. Journal of Pediatric Gastroenterology Nutrition, 39, 219–220.CrossRefGoogle Scholar
  44. Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., et al. (2002). All in the family: Evaluation of the process and content of sisters’ communication about BRCA1and BRCA2genetic test results. American Journal of Medical Genetics, 107(143), 150.Google Scholar
  45. Jass, J. R., Williams, C. B., Bussey, H. J., & Morson, B. C. (1988). Juvenile polyposis–a precancerous condition. Histopathology, 13, 619–630.PubMedCrossRefGoogle Scholar
  46. Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomäki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118, 829–834.PubMedCrossRefGoogle Scholar
  47. Kreusel, K. M., Bechrakis, N. E., Krause, L., Neumann, H. P., & Foerster, M. H. (2006). Retinal angiomatosis in von Hippel-Lindau disease: A longitudinal ophthalmologic study. Ophthalmology, 113, 1418–1424.PubMedCrossRefGoogle Scholar
  48. Lairmore, T. C., Piersall, L. D., DeBenedetti, M. K., Dilley, W. G., Mutch, M. G., Whelan, A. J., et al. (2004). Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Annals of Surgery, 239, 637–645.PubMedCrossRefGoogle Scholar
  49. Lerman, C., Hughes, C., Lemon, S. J., Main, D., Snyder, C., Durham, C., et al. (1998). What you don’t know can hurt you: Adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline testing. Journal of Clinical Oncology, 16, 1650–1654.PubMedGoogle Scholar
  50. Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfelt, S., Lu, K. H., et al. (2006). Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. Journal of the American Medical Association, 296, 1507–1517.PubMedCrossRefGoogle Scholar
  51. Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: A study of emotional impact. Journal of Medical Genetics, 38, 519–526.PubMedCrossRefGoogle Scholar
  52. Myriad Genetic Laboratories (2010). Letter from Dr. Gregory C. Critchfield, President, Myriad Genetic Laboratories, Inc. to Dr. Steven Teutsch, Chair, Secretary’s Advisory Committee on Genetics, Health and Society (January 15, 2010).Google Scholar
  53. NIH Consensus Development Conference. (1988). Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Archives of Neurology, 45, 575–578.CrossRefGoogle Scholar
  54. National Comprehensive Cancer Network. (2010). NCCN clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian. V.1.2010. Retrieved April 5, 2010, from http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf
  55. Offit, K. (2008). Genomic profiles for disease risk: Predictive or premature? Journal of the American Medical Association, 299, 1353–1355.PubMedCrossRefGoogle Scholar
  56. Offit, K., Sagi, M., & Hurley, K. (2006). Preimplantation genetic diagnosis for cancer syndromes: A new challenge for preventive medicine. Journal of the American Medical Association, 296, 2727–2730.PubMedCrossRefGoogle Scholar
  57. Olivier, M., Goldgar, D. E., Sodha, N., Ohgaki, H., Kleihues, P., Hainaut, P., et al. (2003). Li-Fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53genotype. Cancer Research, 63, 6643–6650.PubMedGoogle Scholar
  58. Oloparde, O. I. (2004). Genetics in clinical cancer care: A promise unfulfilled among minority populations. Cancer Epidemiology, Biomarkers, and Prevention, 13, 1683–1686.Google Scholar
  59. Pakakasama, S., & Tomlinson, G. E. (2002). Genetic predisposition and screening in pediatric cancer. Pediatric Clinics of North America, 49, 1393–1413.PubMedCrossRefGoogle Scholar
  60. Patenaude, A. F., Basili, L., Fairclough, D. L., & Li, F. P. (1996). Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. Journal of Clinical Oncology, 14, 415–421.PubMedGoogle Scholar
  61. Peshkin, B. N., DeMarco, T. A., Garber, J. A., Valdimarsdottir, H. B., Patenaude, A. F., Schneider, K. A., et al. (2008, April 1). Brief assessment of parents’ attitudes toward testing minor children for hereditary breast/ovarian cancer genes: Development and validation of the Pediatric BRCA1/2Testing Attitudes Scale (P-TAS). Journal of Pediatric Psychology. (epub ahead of print).Google Scholar
  62. Priesemann, M., Davies, K. M., Perry, L. A., Drake, W. M., Chew, S. L., Monson, J. P., et al. (2006). Benefits of screening in von Hippel-Lindau disease–comparison of morbidity associated with initial tumours in affected parents and children. Hormone Research, 66, 1–5.PubMedCrossRefGoogle Scholar
  63. Ross, J. A., Spector, L. G., Robison, L. L., & Olshan, A. F. (2005). Epidemiology of leukemia in children with Down syndrome. Pediatric Blood and Cancer, 44, 8–12.PubMedCrossRefGoogle Scholar
  64. Sharif, S., Moran, A., Huson, S. M., Iddenden, R., Shenton, A., Howard, E., et al. (2007). Women with neurofibromatosis 1 are at moderately increased risk of developing breast cancer and should be considered for early screening. Journal of Medical Genetics, 44, 481–484.PubMedCrossRefGoogle Scholar
  65. Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K., et al. (2003). Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH. New England Journal of Medicine, 348, 791–799.PubMedCrossRefGoogle Scholar
  66. Strahm, B., & Malkin, D. (2006). Hereditary cancer predisposition in children: Genetic basis and clinical implications. International Journal of Cancer, 119, 2001–2006.CrossRefGoogle Scholar
  67. Tercyak, K. P., Hughes, C., Main, D., Snyder, C., Lynch, J. F., Lynch, H. T., et al. (2001a). Parental communication of BRCA1/2genetic test results to children. Patient Education and Counseling, 42, 213–224.PubMedCrossRefGoogle Scholar
  68. Tercyak, K. P., Peshkin, B. N., DeMarco, T. A., Brogan, B. M., & Lerman, C. (2002). Parent-child factors and their effect on communicating BRCA1/2test results to children. Patient Education and Counseling, 47, 145–153.PubMedCrossRefGoogle Scholar
  69. Tercyak, K. P., Peshkin, B. N., DeMarco, T. A., Patenaude, A. F., Schneider, K. A., Garber, J. E., et al. (2007). Information needs of mothers regarding communicating BRCA1/2cancer genetic test results to their children. Genetic Testing, 11, 249–255.PubMedCrossRefGoogle Scholar
  70. Tercyak, K. P., Peshkin, B. N., Streisand, R., & Lerman, C. (2001b). Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants. Psycho-oncology, 10, 336–346.PubMedCrossRefGoogle Scholar
  71. Tischkowitz, M., & Rosser, E. (2004). Inherited cancer in children: Practical/ethical problems and challenges. European Journal of Cancer, 40, 2459–2470.PubMedCrossRefGoogle Scholar
  72. van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Brocker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., et al. (2007a). Comparison of individuals opting for BRCA1/2or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Education and Counseling, 65, 58–68.PubMedCrossRefGoogle Scholar
  73. van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Brocker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., et al. (2007b). A prospective study of the impact of genetic susceptibility testing for BRCA1/2or HNPCC on family relationships. Psycho-Oncology, 16, 320–328.PubMedCrossRefGoogle Scholar
  74. van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Bröcker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., et al. (2006). Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Annals of Oncology, 17, 1090–1095.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Jennifer E. Axilbund
    • 1
  • Beth N. Peshkin
    • 2
  1. 1.Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimoreUSA
  2. 2.Georgetown University Medical CenterWashingtonUSA

Personalised recommendations